Annoucement - Quest Diagnostics Acquires LabOne
Date: November 01, 2005
Quest Diagnostics, the nation's leading provider of diagnostic testing, has announced the recent acquisition of LabOne, Inc. The combination of the two companies, with complementary operations that are dedicated to quality, service and innovation, will significantly enhance their customer access and service.
What this means to you, our clients, is additional collection sites, innovative technologies and the most extensive testing menu available. Here is what coming together to serve you better will include:
> An expanded test menu
- New, FDA-cleared screening test for oxycodone
- Alcohol testing using urine ethyl glucuronide (EtG),offering an 80-hour detection window
- Medical professional testing panels
- Steroid testing
- Ecstasy testing
> Multiple specimen testing options
- Lab-based testing for drug and alcohol using:
- Urine
- Oral fluid
- Hair
- Blood
- Instant, on-site urine, oral fluid and breath-alcohol testing options
> Faster specimen transportation
A national fleet of 4,000 company-owned couriers-including
a company-owned aviation department-delivers fast and reliable
specimen transportation
> National collection site network
With company-owned or managed drug testing collection sites
in every state and over 2,000 nationwide, finding a convenient
collection site is easy for you and your employees
> Enhanced access
A national network of SAMHSA-Certified Laboratories located
strategically across the nation means faster specimen transport
time and industry-leading results turnaround
> More employee testing options
Clinical laboratory testing for safety and OSHA compliance